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Exclusive biomedical instrument capable of safely imaging 
animal physiology set to advance medical treatments
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Don’t let their beady eyes, large incisors 
and tail fool you: Rodents may hold the keys 
for medical breakthroughs in treating cancer 
and other infectious diseases in animals and 
humans.
That’s the focus a team of chemists, 
veterinarians and an electrical and computer 
engineer at Kansas State University are 
taking in a multidisciplinary approach to 
biomedicine. The researchers designed a 
one-of-a-kind biomedical instrument that 
heats specific cells in the body using a process 
called radiofrequency hyperthermia, which 
mimics how the body uses fever to fight 
infections. As the targeted cells are heated, the 
instrument produces high-resolution images 
of cells and internal organs. This enables 
researchers to monitor the heat’s effects on 
inflamed cells and tumors in real time.
“By applying hyperthermia to a specific 
area of the body, we can really see what’s 
happening at a very fine cellular level,” said 
Stefan Bossmann, professor of chemistry and 
project lead. “When we see the physiological 
effect and heat distribution pattern in 
real time, we can tailor our techniques 
accordingly as we treat small animal patients 
with infections, cancers and other diseases.”
Those small animal patients receiving 
personalized biomedicine will be rodents.
As the rodents are treated of their 
diseases, the techniques and information 
will be applied to help larger animals with 
similar illnesses. The research also may usher 
in personalized hyperthermia treatment for 
humans, Bossmann said.
High-tech approach
The National Science Foundation’s Major 
Research Institute is funding the $1.9 million 
biomedical instrument — a modified wide-
bore 600-megahertz magnetic resonance 
imaging spectrometer with a custom imaging 
probe. Because it is the first of its kind, parts 
are being crafted in Switzerland and France 
before the device is assembled in Germany 
and then shipped to Kansas State University.
Leila Maurmann, nuclear magnetic 
resonance/instrumentation manager in 
the chemistry department, will oversee 
the instrument after its installation at the 
university.
Rodents up to the size of a guinea pig are 
put inside what looks like a small spaceship, 
which is filled with air and an anesthetic 
gas so that they fall asleep. The craft travels 
up an elevator of compressed air and into 
a chamber of coils. The coils and custom imaging probe scan the 
rodent and computer software maps the rodent in 100-by-100 
micrometer sections to produce a 3-D voxel-based image of the body, 
internal organs and any tumors.
Rodents are not harmed at any point in the process or the exam.
The instrument’s software is being written by Punit Prakash, 
an assistant professor of electrical and computer engineering who 
researches radiofrequency hyperthermia. He also is developing the 
unique magnetic resonance imaging probe that makes it possible to 
produce high-resolution images and conduct targeted thermal cell 
therapy at the same time.
Studies with the device are expected to begin in October.
Divide and conquer
Deryl Troyer, a professor of anatomy and physiology who 
specializes in developmental defects and stem cell biotechnology, is 
collaborating with Bossmann and others on using hyperthermia and 
nanoparticles to treat cancer. Stem cells from the Wharton’s jelly of 
umbilical cords as well as defensive cells are used to cloak magnetic 
nanoparticles and traffic them to tumors. A radio-frequency field 
heats the nanoparticles, overheating the tumor and killing it.
“The key is that as we get feedback from the instrument, we can 
fine-tune it and refine this treatment method to a greater extent,” 
Troyer said.
Sanjeev Narayanan, associate professor of diagnostic medicine 
and pathobiology, will use the instrument to help treat the infectious 
disease Fusobacterium necrophorum — a bacteria that causes necrotic 
lesions on cattle’s livers and causes cattle to grow more slowly. 
A more deconstructed system that uses radio-frequency antennas 
to generate a similar analysis will be built for use on cattle and other 
large animals in the field.
Additionally, Bossmann said the instrument’s hardware can be 
adjusted so that researchers can work with heart disease and other 
cardiovascular diseases.
“With this technology we can then start building integrated 
therapies,” Bossmann said. “We have heat therapy, chemotherapeutics, 
can recruit defensive cells, and now will have an integrated piece of 
equipment that will be a springboard to do integrated therapy using 
these methods. There is no golden bullet to make advanced infectious 
diseases and cancer magically go away. They are systemic diseases and 
they have to be beaten with systemic methods.”
According to Bossmann, the project’s interdisciplinary approach 
— from construction to conducting research — is imperative to 
success with the biomedical instrument.
“It starts the dialog and teaching of a common language that 
researchers can take back to their departments and translate for 
others in their discipline,” Bossmann said. “For example, Deryl can 
talk to the veterinary medicine researchers and explain the project in 
their language and I can do the same with the people in chemistry. 
This allows us to get third parties in faster because we can translate 
to different groups of people.”
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